Catch Cancer at Its Most Survivable Stage
You know my philosophy: catch things early, while you still have the most options. Nothing makes that case more urgently than cancer. I’ve partnered with Cancer Check Labs to offer a screening tool I’ve been evaluating closely – and its approach is meaningfully different from the multi-cancer blood tests you may have heard about.
It looks for the cancer cells themselves
Most of the new multi-cancer blood tests hunt for fragments of tumor DNA and use an algorithm to guess whether cancer might be present. Cancer Check takes a different route. It isolates whole circulating tumor cells – intact malignant cells that have broken away from a solid tumor and entered the bloodstream – so their presence points to active cancer, not just genetic risk. Because the whole cell is captured, a board-certified pathologist examines it under the microscope using the same gold-standard methods used in conventional biopsies. Real cells, examined by a real pathologist – no guesswork from broken DNA fragments.
A whole-body screen, not one organ at a time
Here’s why early matters so much: most cancers are still found only after symptoms appear, and the majority of cancer deaths come from cancers that have no routine screening test at all – no mammogram, no colonoscopy, nothing. Because essentially all solid tumors shed these cells, Cancer Check can screen for more than 200 types and subtypes of solid tumor cancer in a single blood draw, including many with no standard screening. And catching cancer early changes everything: at Stage 0, many cancers carry survival rates near 99%, with far less aggressive treatment.
My honest take
I’m genuinely excited about this technology, and I want you to understand it clearly. The lab is CLIA-certified, but the test is not FDA-cleared, and like every test it has limitations and won’t catch every cancer. It does not replace your mammogram, colonoscopy, or skin checks – it adds to them, filling the gap they leave behind. And if a result does come back positive, that’s not the end of the story – it’s the starting point for targeted follow-up, imaging and testing to confirm the finding and locate its source.
Available now through my office
As I bring Cancer Check into my practice, I’m offering an introductory patient rate of $1,595 (the test’s standard price is $1,995). Like other advanced early-detection tests, it isn’t covered by insurance yet, so it’s an out-of-pocket investment in catching what standard screenings can’t. Many patients use HSA or FSA funds for the screening. Eligibility varies by plan, so confirm with your plan administrator first. Call 516-829-1515 to schedule, or just reply with any questions.
Educational only; not a substitute for individualized medical advice, diagnosis, or treatment. The Cancer Check test does not diagnose, treat, cure, or prevent any disease and does not replace established cancer-screening guidelines. |